High resolution genome-wide Massively Parallel Sequencing (MPS)




By combining increased sequencing depth with industry-leading expertise in prenatal diagnostics, the PrenatalSAFE® Karyo test offers a breadth of resolution unlike any other noninvasive prenatal test available to date.


PrenatalSAFE®Karyo uses more sequence reads than other NIPT’s (>50 Millions).

More sequence reads equals higher resolution, greater sensitivity and precision.

maternal blood

A groundbreaking technology allowing for a screening test that is revolutionary

Accurate fetal fraction determination

The test determines the quantity of cell-free fetal DNA (cfDNA) present in the maternal plasma (fetal fraction), and uniquely includes the analysis of cell-free DNA fragment size, allowing distinction between maternal and fetal cell-free DNA, for the highest accuracy.